--- title: "IMMUDEX ApS – CVR 31348854, financials and ownership" description: "IMMUDEX ApS (CVR 31348854). Active · Forskning og eksperimentel udvikling inden for naturvidenskab og teknik · Virum. 37 employees (CVR). Gross profit 22.7M DKK (2025)." canonical_url: "https://datapublica.dk/en/companies/31348854-immudex-aps" locale: "en" route_type: "company_overview" robots: "index,follow" --- # IMMUDEX ApS IMMUDEX ApS \(CVR 31348854\). Active · Forskning og eksperimentel udvikling inden for naturvidenskab og teknik · Virum. 37 employees \(CVR\). Gross profit 22.7M DKK \(2025\). CVR number: 31348854 ## Company details - **CVR number:** 31348854 - **Status:** Aktiv - **Address:** Bredevej 2A, 2830, Virum - **Legal form:** Anpartsselskab \(ApS\) - **Founded:** Apr 1, 2008 - **Employees \(CVR\):** 37 - **Production units:** 1 - **Website:** https://www.immudex.com/ ## Description Description of key activities of the companyThe main activities of Immudex are to provide MHC Dextramer® reagents and services for improved cellular immune monitoring to be used in research, clinical development and patient monitoring. The Company has during the fiscal year had the following focus areas: i. Increase sales of clinical-grade Dextramer \(GMP\) reagents to biophama companies engaged in T-cell therapy development ii. Increase output of new products and services by investing in more R&D activities, and we launched several new products in the year iii. Expand commercial activities The year was another difficult year as many of our biopharma companies experienced slow down in their pipelines due to lack of financing. We saw therefore a low increase in sales. Immudex continued to invest significant resources in 1\) the development of new Dextramer® reagents, 2\) in expanding commercial activities 3\) maintaining and protecting existing patent portfolio. In the next financial year, a continued expansion of Immudex’ product portfolio will take place. Immudex is entering new clinical application areas, such as CAR-T, Autoimmunity, to continue to expand the available markets for the company. ## Activities and industry - Forskning og eksperimentel udvikling inden for naturvidenskab og teknik - 721000 — Forskning og eksperimentel udvikling inden for naturvidenskab og teknik ## Latest financial period - **Reporting period:** 2024/25 \(1 Jul 2024 - 30 Jun 2025\) - **Currency:** DKK - **Gross profit:** 22,665,406 - **Operating profit:** -10,987,916 - **Profit after tax:** -11,025,449 - **Assets:** 49,096,111 - **Equity:** 16,050,190 ## People | Person | Roles | Titles | | --- | --- | --- | | [Hans Christian Barré Pedersen](https://datapublica.dk/en/people/pid_entity_4010275223-hans-christian-barr-pedersen) | Board | BESTYRELSESMEDLEM | | [Jamil El-Ali](https://datapublica.dk/en/people/pid_entity_4010583264-jamil-el-ali) | Board | BESTYRELSESMEDLEM | | [Søren Elmann Ingerslev](https://datapublica.dk/en/people/pid_entity_4004097184-s-ren-elmann-ingerslev) | Board | FORMAND | | [Patrik Olof Dahlén](https://datapublica.dk/en/people/pid_entity_4004071902-patrik-olof-dahl-n) | Management | ADM. DIR. | ## Auditor | Audit firm | Auditor | Role | From | | --- | --- | --- | --- | | Powered-By, Statsautoriseret Revisionspartnerselskab | Søren Strandby | statsautoriseret revisor | Nov 13, 2025 | ## Contact ### From [cvr.dk](https://datacvr.virk.dk/) | Contact | Phone | Email | | --- | --- | --- | | Company | 3110\*\*\*\* [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F31348854-immudex-aps) | \*\*@immudex.com [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F31348854-immudex-aps) | Branches \(1\) IMMUDEX ApS · Bredevej 2A · P-1014323844 | Contact | Phone | Email | | --- | --- | --- | | Company | 3110\*\*\*\* [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F31348854-immudex-aps) | h\*\*@immudex.com [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F31348854-immudex-aps) | ## Legal owners ### Current | Owner | Ownership | Voting rights | From | | --- | --- | --- | --- | | OwnerVIGGO HARBOE 2006 HOLDING ApS | Ownership50–66.66 % | Voting rights50 % | FromFeb 6, 2017 | | OwnerGUNNERSEN MARKER HOLDING ApS | Ownership20–24.99 % | Voting rights20 % | FromJun 18, 2020 | | OwnerHJECA HOLDING I ApS | Ownership5–9.99 % | Voting rights5 % | FromFeb 14, 2017 | ### Previous | Owner | Ownership | Voting rights | From | To | | --- | --- | --- | --- | --- | | OwnerGUNNERSEN MARKER HOLDING ApS | Ownership25–33.32 % | Voting rights25 % | FromNov 14, 2014 | ToJun 17, 2020 | | OwnerCHEMGENE ApS | Ownership10–14.99 % | Voting rights10 % | FromNov 9, 2015 | ToFeb 6, 2017 | | OwnerVIGGO HARBOE 2006 HOLDING ApS | Ownership33.33–49.99 % | Voting rights33.33 % | FromNov 9, 2015 | ToFeb 5, 2017 | | OwnerHJECA HOLDING I ApS | Ownership5–9.99 % | Voting rights5 % | FromOct 16, 2015 | ToNov 8, 2015 | | OwnerCHEMGENE ApS | Ownership15–19.99 % | Voting rights15 % | FromDec 5, 2014 | ToNov 8, 2015 | | OwnerVIGGO HARBOE 2006 HOLDING ApS | Ownership25–33.32 % | Voting rights25 % | FromNov 14, 2014 | ToNov 8, 2015 | ## Ultimate owners [View ownership diagram](https://datapublica.dk/en/companies/31348854-immudex-aps/portfolio) | Name | Ownership through | Calculated ownership | | --- | --- | --- | | Viggo Gunnersen Harboe | VIGGO HARBOE 2006 HOLDING ApS | 50–66.66 % | | Helene Kähler Hjenner | HJECA HOLDING I ApS | 5–9.99 % | | Emil Peter Skov Marker | GUNNERSEN MARKER HOLDING ApS | 3–5 % | | Julie Bacher Marker | GUNNERSEN MARKER HOLDING ApS | 3–5 % | | Lucas Peter Skov Marker | GUNNERSEN MARKER HOLDING ApS | 3–5 % | | Marie Bacher Marker | GUNNERSEN MARKER HOLDING ApS | 3–5 % | | Rosemarie Ida Skov Marker | GUNNERSEN MARKER HOLDING ApS | 3–5 % | | Sarah Bacher Marker | GUNNERSEN MARKER HOLDING ApS | 3–5 % | | Anders Johannes Skov Marker | Marskov Holding ApS → FORCE INVEST ApS → GUNNERSEN MARKER HOLDING ApS | 1–2.5 % | | Morten Kofoed Marker | Karmo Holding ApS → FORCE INVEST ApS → GUNNERSEN MARKER HOLDING ApS | 1–2.5 % | ## Company pages - [Overview](https://datapublica.dk/en/companies/31348854-immudex-aps) - [Financial report](https://datapublica.dk/en/companies/31348854-immudex-aps/financials) - [Risk](https://datapublica.dk/en/companies/31348854-immudex-aps/risk) - [Timeline](https://datapublica.dk/en/companies/31348854-immudex-aps/timeline) - [Ownership and relations](https://datapublica.dk/en/companies/31348854-immudex-aps/portfolio) - [Production units](https://datapublica.dk/en/companies/31348854-immudex-aps/production-units) - [Gazelle](https://datapublica.dk/en/companies/31348854-immudex-aps/gazelle) - [Investments](https://datapublica.dk/en/companies/31348854-immudex-aps/investments) - [Company website](https://www.immudex.com/) ## Official sources - [Official CVR record on Virk](https://datacvr.virk.dk/enhed/virksomhed/31348854)